Table 3. Cox Regression Analysis for OS, LRFS, and DMFS.
OS: overall survival; LRFS: local recurrence-free survival; DMFS: distant metastasis-free survival; HR: hazard ratio
OS | LRFS | DMFS | ||||||||
Covariates | Hazard ratio | 95% CI | P-value | HR | 95% CI | P-value | HR | 95% CI | P-value | |
TStage | 1.41 | 1.04 - 1.91 | 0.027 | 1.154 | 0.86 - 1.54 | 0.327 | 1.808 | 1.43 - 2.29 | < 0.001 | |
N Stage | 1.802 | 1.38 - 2.35 | < 0.001 | 1.64 | 1.29 - 2.09 | < 0.001 | 1.892 | 1.53 - 2.34 | < 0.001 | |
Grade | 1.27 | 0.732 - 2.21 | 0.393 | 1.19 | 0.73 - 1.94 | 0.487 | 1.105 | 0.706 - 1.730 | 0.661 | |
Molecular Type | 1.737 | 1.39 - 2.17 | < 0.001 | 1.66 | 1.36 - 2.02 | < 0.001 | 1.644 | 1.371 - 1.973 | < 0.001 |
Covariate | HR | 95% CI | P value |
Age (≤ 44 vs > 44) | 0.809 | 0.44 - 1.49 | 0.498 |
Menopausal Status (pre vs post) | 0.839 | 0.52 - 1.36 | 0.477 |
T-stage | 1.94 | 1.53 - 2.46 | < 0.001 |
N-stage | 2.14 | 1.6 - 2.72 | < 0.001 |
Tumor Grade | 3.27 | 2.09 - 5.12 | < 0.001 |
Histology | 0.838 | 0.67 - 1.04 | 0.113 |
Chemotherapy | 0.69 | 0.44 - 1.08 | 0.104 |
Boost | 1.49 | 0.94 - 2.35 | 0.086 |
Molecular Subtypes | 1.836 | 1.54 - 2.19 | < 0.001 |